LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/HealthCareEquipment?src=hash" target="_blank"gt;#HealthCareEquipmentlt;/agt;–The global cell isolation market is expected to post a CAGR close to 19%
during the period 2019-2023, according to the latest market research
report by Technavio.
The growing incidences of chronic diseases have increased the need for
cell-based therapies. Cell isolation is an essential step in various
experiments during diagnostics and research of chronic diseases as it is
crucial to study how cells respond to conditions, and how they are
affected by drugs. Cell isolation tools are increasingly used in drug
discovery techniques to generate recombinant protein therapeutics, which
can treat a variety of chronic diseases. Moreover, the wide applications
of isolated human cells in research, drug development, and clinical
trials are increasing with growing incidences of chronic diseases
globally. Hence, the rising prevalence of chronic diseases increases the
need for cell-based therapies, which, in turn, increases the demand for
cell isolation tools.
As per Technavio, the increasing product advances will have a positive
impact on the market and contribute to its growth significantly over the
forecast period. This global
cell isolation market 2019-2023 research report also
analyzes other important trends and market drivers that will affect
market growth over 2019-2023.
Global cell isolation market: Product advances
Product innovations in the global cell isolation market are driven by
the increasing demand for automation in tools for cell-based research
for various chronic and infectious diseases. For instance, in 2017,
Miltenyi Biotec launched the automated MukiMACS X device, which enables
parallel and reliable processing of up to 24 samples or large volumes.
This fully automated solution reduces labor and minimizes contamination
risks and help researchers in the quick analysis. Other vendors such as
BD and QIAGEN are focusing on continuous product advances. In March
2019, BD launched BD FACSDuet automated flow cytometry system. The new
fully automated sample preparation instrument enables clinical
laboratories to improve their efficiency by reducing errors and limiting
the manual user interactions required to run assays on the clinical flow
cytometer. Thus, continuous product advances by existing players drive
the market growth and boost the sales of the products.
“Currently, research institutes and pharmaceutical companies are
making significant investments in cell-based drug development to provide
better treatment options to patients. Cell-based research is targeted at
finding new drugs and finding novel cell-based therapies for patients
with various chronic conditions. Also, the increasing government funding
for cell-based and genetic engineering projects in academic institutes
and research laboratories is expected to propel the growth of the global
cell isolation market during the forecast period,” says a senior
analyst at Technavio.
Global cell isolation market: Segmentation
analysis
This market research report segments the global cell isolation market by
end-user (AR, PB, CRO, others), by product (consumables and instruments)
and geographical regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe,
Asia, and ROW respectively. However, during the forecast period, the
Asian region is expected to register the highest incremental growth due
to the increasing applications of cell-based research on genetic
engineering in the pharmaceutical and biotechnology industries.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com